Dr. Emily Lovallo, MD

Dr. Lovallo practices at UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Lovallo's NPI, 1225316508, was assigned on August 3, 2011. Dr. Lovallo graduated from Georgetown University School of Medicine in 2006. Dr. Lovallo holds Pennsylvania license MD454762.

Dr. Lovallo's primary practice is UPMC Mercy, at 1400 Locust Street, Pittsburgh, PA 15219 in Allegheny County. The practice phone is (412) 232-8111.

Dr. Lovallo's primary practice is UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Lovallo is also affiliated with UPMC Magee-Womens Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Lovallo to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lovallo practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Lovallo's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Lovallo's licenses on file in 2 states: Pennsylvania and California.

CMS data shows 141 Medicare services from Dr. Lovallo across 4 procedure codes in 2024, for 121 Medicare patients. Medicare paid $12,065 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Lovallo in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lovallo's median patient age at 67, with 55% women.

In 2024, Dr. Lovallo wrote 73 Medicare Part D claims for 54 patients. 95% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $89 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Lovallo for performance year 2024, reported as part of a group. Dr. Lovallo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Lovallo, published from 2013 to 2018. The most frequent topics are Ultrasonography. Dr. Lovallo's most frequent co-authors are Timur Shah Durrani, MD, Brian D. Johnson, MD and Daniel R. Mantuani, MD.

CMS Open Payments shows 4 general payments to Dr. Lovallo from 2 drug and device companies in 2024. Device or supply loans make up the largest share, 82% of the total. Exo Imaging, Inc. paid the most, $4,250.

Dr. Lovallo graduated from Georgetown University School of Medicine in 2006.